Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.

by Sung Su Yea, Lomon So, Sharmila Mallya, Jongdae Lee, Kamalakannan Rajasekaran, Subramaniam Malarkannan, David A Fruman
Published 2014-01-01

Correction: Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.

by Ju Mi Jeon, Oh Kwang Kwon, Ann-Yae Na, Eun Ji Sung, Il Je Cho, Mirae Kim, Sung Su Yea, So Young Chun, Jun Nyung Lee, Yun-Sok Ha, Tae Gyun Kwon, Sangkyu Lee
Published 2019-01-01

Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.

by Ju Mi Jeon, Oh Kwang Kwon, Ann-Yae Na, Eun Ji Sung, Il Je Cho, Mirae Kim, Sung Su Yea, So Young Chun, Jun Hyung Lee, Yun-Sok Ha, Tae Gyun Kwon, Sangkyu Lee
Published 2019-01-01

A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice

by Jae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, Hana Jung, Anbok Lee, Ji-Young Lee, Joo Yeon Song, Seung Jae Park, Ilhwan Kim, Won-Sik Lee, Su-Kil Seo, Il-Whan Choi, Yang-Xin Fu, Sung Su Yea, SaeGwang Park
Published 2018-05-01